{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:09:11Z","timestamp":1790629751526,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.vaccine.2011.03.027","type":"journal-article","created":{"date-parts":[[2011,4,15]],"date-time":"2011-04-15T14:26:08Z","timestamp":1302877568000},"page":"3802-3810","source":"Crossref","is-referenced-by-count":30,"title":["Evaluation of a broadly protective Chlamydia\u2013cholera combination vaccine candidate"],"prefix":"10.1016","volume":"29","author":[{"given":"F.O.","family":"Eko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.N.","family":"Okenu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.U.","family":"Igietseme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.03.027_bib0005","series-title":"Chlamydial infections","first-page":"3","article-title":"Epidemiology of human chlamydial infections","author":"Schachter","year":"1998"},{"key":"10.1016\/j.vaccine.2011.03.027_bib0010","doi-asserted-by":"crossref","first-page":"S519","DOI":"10.1016\/S0002-8703(99)70291-7","article-title":"Transgene as vaccine for Chlamydia","volume":"138","author":"Brunham","year":"1999","journal-title":"Am Heart J"},{"issue":"6","key":"10.1016\/j.vaccine.2011.03.027_bib0015","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1128\/JCM.41.6.2700-2702.2003","article-title":"Predominance of Chlamydia trachomatis serovars associated with urogenital infections in females in New Delhi, India","volume":"41","author":"Singh","year":"2003","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2011.03.027_bib0020","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1128\/JCM.02076-06","article-title":"Distribution study of Chlamydia trachomatis serovars among high-risk women in China performed using PCR\u2013restriction fragment length polymorphism genotyping","volume":"45","author":"Gao","year":"2007","journal-title":"J Clin Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2011.03.027_bib0025","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1099\/jmm.0.008607-0","article-title":"Genotyping of Chlamydia trachomatis from the endocervical specimens of high-risk women in Hungary","volume":"58","author":"Petrovay","year":"2009","journal-title":"J Med Microbiol"},{"issue":"9","key":"10.1016\/j.vaccine.2011.03.027_bib0030","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/01.olq.0000258399.27873.d9","article-title":"Genotyping of Chlamydia trachomatis from endocervical specimens in Brazil","volume":"34","author":"Lima","year":"2007","journal-title":"Sex Transm Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2011.03.027_bib0035","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1586\/14760584.2.1.129","article-title":"Contemporary approaches to designing and evaluating vaccines against Chlamydia","volume":"2","author":"Igietseme","year":"2003","journal-title":"Expert Rev Vaccines"},{"issue":"4","key":"10.1016\/j.vaccine.2011.03.027_bib0040","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S1357-4310(98)01232-5","article-title":"Vaccines against Chlamydia: approaches and progress","volume":"4","author":"Stagg","year":"1998","journal-title":"Mol Med Today"},{"issue":"6","key":"10.1016\/j.vaccine.2011.03.027_bib0045","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1128\/IAI.70.6.2741-2751.2002","article-title":"Immunity to murine chlamydial genital infection","volume":"70","author":"Morrison","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.027_bib0050","first-page":"218","article-title":"Chlamydia trachomatis antigens: role in immunity and pathogenesis","volume":"3","author":"Brunham","year":"1994","journal-title":"Infect Agents Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2011.03.027_bib0055","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/0264-410X(95)00017-U","article-title":"Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: serum neutralizing IgG antibodies do not protect against genital tract infection","volume":"13","author":"Su","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.03.027_bib0060","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/S0264-410X(02)00677-1","article-title":"Recombinant Vibrio cholerae ghosts as a delivery vehicle for vaccinating against Chlamydia trachomatis","volume":"21","author":"Eko","year":"2003","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2011.03.027_bib0065","doi-asserted-by":"crossref","first-page":"6240","DOI":"10.1128\/IAI.69.10.6240-6247.2001","article-title":"Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein can elicit a protective immune response against a genital challenge","volume":"69","author":"Pal","year":"2001","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2011.03.027_bib0070","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1365-2567.2007.02608.x","article-title":"Live-attenuated influenza viruses as delivery vectors for Chlamydia vaccines","volume":"122","author":"He","year":"2007","journal-title":"Immunology"},{"issue":"5389","key":"10.1016\/j.vaccine.2011.03.027_bib0075","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1126\/science.282.5389.754","article-title":"Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis","volume":"282","author":"Stephens","year":"1998","journal-title":"Science"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2011.03.027_bib0080","doi-asserted-by":"crossref","first-page":"S521","DOI":"10.1086\/315631","article-title":"Chlamydial genomics and vaccine antigen discovery","volume":"181","author":"Stephens","year":"2000","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2011.03.027_bib0085","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1128\/IAI.69.4.2383-2389.2001","article-title":"Expression of Chlamydia pneumoniae polymorphic membrane protein family genes","volume":"69","author":"Grimwood","year":"2001","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2011.03.027_bib0090","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1086\/375827","article-title":"Polymorphic membrane protein (PMP) 20 and PMP 21 of Chlamydia pneumoniae induce proinflammatory mediators in human endothelial cells in vitro by activation of the nuclear factor-kappaB pathway","volume":"188","author":"Niessner","year":"2003","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2011.03.027_bib0095","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1046\/j.1365-2958.2000.02167.x","article-title":"Characterization and functional analysis of PorB, a Chlamydia porin and neutralizing target","volume":"38","author":"Kubo","year":"2000","journal-title":"Mol Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2011.03.027_bib0100","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1073\/pnas.0508983103","article-title":"From the cover: Chlamydia trachomatis polymorphic membrane protein D is a species-common pan-neutralizing antigen","volume":"103","author":"Crane","year":"2006","journal-title":"PNAS"},{"key":"10.1016\/j.vaccine.2011.03.027_bib0105","first-page":"188","article-title":"Immunogenicity and protection against genital Chlamydia infection and its complications by a multisubunit candidate vaccine","volume":"40","author":"Ifere","year":"2007","journal-title":"J Microbiol Immunol Infect"},{"issue":"5","key":"10.1016\/j.vaccine.2011.03.027_bib0110","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.4049\/jimmunol.173.5.3375","article-title":"A novel recombinant multisubunit vaccine against Chlamydia","volume":"173","author":"Eko","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.03.027_bib0115","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/infdis\/166.1.2","article-title":"The treatment of cholera: clinical science on the bedside","volume":"166","author":"Carpenter","year":"1992","journal-title":"J Infect Dis"},{"issue":"9758","key":"10.1016\/j.vaccine.2011.03.027_bib0120","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1016\/S0140-6736(10)62243-X","article-title":"Five complementary interventions to slow cholera: Haiti","volume":"376","author":"Ivers","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2011.03.027_bib0125","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0020-2452(96)85759-9","article-title":"Live cholera vaccines: perspectives on their construction and safety","volume":"93","author":"Mekalanos","year":"1995","journal-title":"Bull Inst Pasteur"},{"issue":"1","key":"10.1016\/j.vaccine.2011.03.027_bib0130","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10719-008-9160-6","article-title":"Investigation towards bivalent chemically defined glycoconjugate immunogens prepared from acid-detoxified lipopolysaccharide of Vibrio cholerae O1, serotype Inaba","volume":"26","author":"Grandjean","year":"2009","journal-title":"Glycoconj J"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2011.03.027_bib0135","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0168-1656(99)00114-5","article-title":"Pathogenic and vaccine significance of toxin-coregulated pili of Vibrio cholerae El Tor","volume":"73","author":"Attridge","year":"1999","journal-title":"J Biotechnol"},{"key":"10.1016\/j.vaccine.2011.03.027_bib0140","series-title":"Vibrio cholerae and cholera. Molecular to global perspectives","first-page":"395","article-title":"Recombinant live cholera vaccines","author":"Levine","year":"1994"},{"key":"10.1016\/j.vaccine.2011.03.027_bib0145","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/S0264-410X(98)00423-X","article-title":"New strategies for combination vaccines based on the extended recombinant bacterial ghost system","volume":"17","author":"Eko","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.03.027_bib0150","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0168-1656(00)00315-1","article-title":"Characterization and immunogenicity of Vibrio cholerae ghosts expressing toxin-coregulated pili","volume":"83","author":"Eko","year":"2000","journal-title":"J Biotechnol"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2011.03.027_bib0155","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1016\/S0264-410X(03)00388-8","article-title":"Evaluation of the protective efficacy of Vibrio cholerae ghost (VCG) candidate vaccines in rabbits","volume":"21","author":"Eko","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.03.027_bib0160","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1574-695X.2006.00165.x","article-title":"A recombinant multivalent combination vaccine protects against Chlamydia and genital herpes","volume":"49","author":"Macmillan","year":"2007","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2011.03.027_bib0165","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1128\/IAI.59.4.1346-1351.1991","article-title":"Susceptibility to reinfection after a primary chlamydial genital infection is associated with a decrease of antigen-specific T cells in the genital tract","volume":"59","author":"Igietseme","year":"1991","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2011.03.027_bib0170","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.vaccine.2010.12.024","article-title":"Induction of immune memory by a multisubunit chlamydial vaccine","volume":"29","author":"Eko","year":"2011","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2011.03.027_bib0175","doi-asserted-by":"crossref","first-page":"5184","DOI":"10.4049\/jimmunol.168.10.5184","article-title":"Antigenic topology of chlamydial PorB protein and identification of targets for immune neutralization of infectivity","volume":"168","author":"Kawa","year":"2002","journal-title":"J Immunol"},{"issue":"31\u201332","key":"10.1016\/j.vaccine.2011.03.027_bib0180","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1016\/j.vaccine.2004.04.035","article-title":"Immune response to the Chlamydia trachomatis outer membrane protein PorB","volume":"22","author":"Kawa","year":"2004","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2011.03.027_bib0185","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1046\/j.1365-2958.2003.03838.x","article-title":"From the inside out \u2013 processing of the chlamydial autotransporter PmpD and its role in bacterial adhesion and activation of human host cells","volume":"51","author":"Wehrl","year":"2004","journal-title":"Mol Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2011.03.027_bib0190","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1128\/IAI.01280-06","article-title":"Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production","volume":"75","author":"Murthy","year":"2007","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2011.03.027_bib0195","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.4049\/jimmunol.180.3.1962","article-title":"Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response","volume":"180","author":"Scriba","year":"2008","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2011.03.027_bib0200","first-page":"2379","article-title":"IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani","volume":"119","author":"Pitta","year":"2009","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.vaccine.2011.03.027_bib0205","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.4049\/jimmunol.0803075","article-title":"A MyD88-dependent early IL-17 production protects mice against airway infection with the obligate intracellular pathogen Chlamydia muridarum","volume":"183","author":"Zhang","year":"2009","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2011.03.027_bib0210","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1128\/IAI.00403-09","article-title":"Critical role of the interleukin-17\/interleukin-17 receptor axis in regulating host susceptibility to respiratory infection with Chlamydia species","volume":"77","author":"Zhou","year":"2009","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2011.03.027_bib0215","doi-asserted-by":"crossref","first-page":"5886","DOI":"10.4049\/jimmunol.0901584","article-title":"IL-17\/Th17 promotes Type 1 T cell immunity against pulmonary intracellular bacterial infection through modulating dendritic cell function","volume":"183","author":"Bai","year":"2009","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2011.03.027_bib0220","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.micinf.2010.10.012","article-title":"Spontaneous secretion of interleukin-17 and -22 by human cervical cells in Chlamydia trachomatis infection","volume":"13","author":"Jha","year":"2011","journal-title":"Microbes Infect"},{"issue":"9","key":"10.1016\/j.vaccine.2011.03.027_bib0225","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1128\/IAI.66.9.4030-4035.1998","article-title":"Route of infection that induces a high intensity of gamma interferon-secreting T cells in the genital tract produces optimal protection against Chlamydia trachomatis infection in mice","volume":"66","author":"Igietseme","year":"1998","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2011.03.027_bib0230","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1046\/j.0019-2805.2001.01354.x","article-title":"Fc receptor regulation of protective immunity against Chlamydia trachomatis","volume":"105","author":"Moore","year":"2002","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.vaccine.2011.03.027_bib0235","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1586\/14760584.3.1.23","article-title":"Antibody regulation of T-cell immunity: implications for vaccine strategies against intracellular pathogens","volume":"3","author":"Igietseme","year":"2004","journal-title":"Expert Rev Vaccines"},{"issue":"11","key":"10.1016\/j.vaccine.2011.03.027_bib0240","doi-asserted-by":"crossref","first-page":"7536","DOI":"10.4049\/jimmunol.175.11.7536","article-title":"A predominant role for antibody in acquired immunity to chlamydial genital tract reinfection","volume":"175","author":"Morrison","year":"2005","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2011.03.027_bib0245","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1128\/CVI.00274-07","article-title":"Induction of cross-serovar protection against genital chlamydial infection by a targeted multisubunit vaccination approach","volume":"14","author":"Li","year":"2007","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2011.03.027_bib0250","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0264-410X(96)00141-7","article-title":"Endotoxicity does not limit the use of bacterial ghosts as candidate vaccines","volume":"15","author":"Mader","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.03.027_bib0255","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/0140-6736(90)90080-O","article-title":"Field trial of oral cholera vaccines in Bangladesh: results from three year follow-up","volume":"335","author":"Clemens","year":"1990","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2011.03.027_bib0260","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.vaccine.2006.09.049","article-title":"Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults","volume":"25","author":"Anh","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.03.027_bib0265","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/infdis\/148.5.931","article-title":"Prophylactic significance of non-lipopolysaccharide antigens of Vibrio cholerae","volume":"148","author":"Attridge","year":"1983","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.03.027_bib0270","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1128\/IAI.59.3.977-982.1991","article-title":"New model for analysis of mucosal immunity:intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholerae infection","volume":"59","author":"Winner","year":"1991","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.027_bib0275","first-page":"202","article-title":"Saliva, breast milk and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease","volume":"24","author":"Jertborne","year":"1986","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2011.03.027_bib0280","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/infdis\/163.6.1235","article-title":"Field trial of oral cholera vaccines in Bangladesh: serum vibriocidal and antitoxic antibodies as markers of the risk of cholera","volume":"163","author":"Clemens","year":"1991","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11003793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11003793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T08:54:57Z","timestamp":1592470497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11003793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":56,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0264410X11003793"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.03.027","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}